IDH1 and central nervous system cancer: Recently, Shibahara et al. demonstrated that IDH wild-type WHO III anaplastic astrocytomas had significantly higher rates of distant recurrence along with increased expression of glioma stem cell markers compared to their IDH-mutated histological counterparts [14].